Skip to main content
. 2003 Sep;163(3):819–826. doi: 10.1016/S0002-9440(10)63442-6

Table 1.

Percentage of Cutaneous Mast Cells Reactive for Bcl-2 and Bcl-xL in Patients with Different Forms of Mastocytosis and Healthy Controls

Patient groups Bcl-2 Bcl-xL
Mean ± SEM (%) n P value Mean ± SEM (%) n P value
All patients with mastocytosis 44.8 ± 4.64 32 0.000 18.99 ± 4.41 30 0.729
All mastocytosis patients with adult onset 53.58 ± 8.18 12 0.000 15.30 ± 8.12 12 0.993
Maculopapular mastocytosis, adult onset 53.58 ± 8.18 12 0.000 15.30 ± 8.12 12 0.993
All mastocytosis patients with childhood onset 39.59 ± 5.23 20 0.000 21.44 ± 4.88 18 0.570
Maculopapular mastocytosis, childhood onset 28.22 ± 6.27 6 0.045 17.50 ± 10.26 6 0.887
Solitary mastocytomas, childhood onset 47.14 ± 8.93 7 0.007 27.17 ± 6.48 6 0.326
Multiple mastocytomas, childhood onset 41.79 ± 9.49 7 0.019 19.67 ± 7.66 6 0.735
All patients with maculopapular mastocytosis 45.13 ± 6.48 18 0.000 16.03 ± 6.41 18 0.956
All patients with mastocytomas 44.46 ± 6.55 14 0.000 23.42 ± 5.13 12 0.460
Healthy controls 9.43 ± 3.65 7 15.41 ± 8.30 7